Philips has ceased distribution to providers in Australia due to a manufacturing concern regarding the sound abatement foam surrounding the motor in their Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.
On the 6th of July 2021, the Therapeutic Goods Administration announced that Philips Electronics Australia Ltd, following consultation with the TGA, is undertaking a ‘product defect correction’ on the specific affected devices. Click here to view the latest TGA update and risk assessment statement.
If you haven’t already, we recommend you to register your affected Philips device to ensure a swift resolution:
We understand the importance in addressing these concerns and will do our best to support our customers, making sure they return to CPAP therapy as soon as possible.
Due to the high volume of devices and patients affected by this product defect correction, we please ask for your patience and understanding, as our team members work hard to answer your questions.